Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?

To: ahhaha who wrote (168)	2/4/1998 1:40:00 PM
From: Peter Silsbee	Read Replies (2) \| Respond to of 399

You make it sound as if ARQL is just reaching into a combinatorically huge basket of possible molecules, picking out a few at random, and hoping that one will prove to be a blockbuster drug. I think that there is a lot more going on than this, and that there is, in fact, a viable stochastic optimization going on. For instance, if one point in the solution space (i.e. one molecule) is found to be promising, a "local search" can be performed. And the problem can be constrained by working closely with an SBD group. You're probably right about the stone knives and bearskins. I imagine that the first people to learn to use these things had a huge advantage over the others. And, good science is not synonymous with failing, failing, failing. Although it is said to build character. PLS